We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.85B
AUM Growth
+$678M
Cap. Flow
-$555M
Cap. Flow %
-8.1%
Top 10 Hldgs %
43.77%
Holding
155
New
30
Increased
19
Reduced
23
Closed
29

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$156M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$119M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$90.9M
4
RLAY icon
Relay Therapeutics
RLAY
+$88.8M
5
CHRS icon
Coherus Oncology
CHRS
+$57.5M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$133M
2
KOD icon
Kodiak Sciences
KOD
+$124M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$68.6M
4
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$54.9M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$52.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.2%
2 Miscellaneous 14.63%
3 Consumer Staples 0.6%
4 Financials 0.25%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LSACU
101
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
$4.08M 0.06%
300,000
– –
MOTS
102
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$4.03M 0.06%
14,035
– –
BNR
103
Burning Rock Biotech
BNR
$123M
$3.76M 0.05%
15,000
– –
ATEC icon
104
Alphatec Holdings
ATEC
$1.65B
$3.73M 0.05%
561,574
– –
ADAP
105
DELISTED
Adaptimmune Therapeutics
ADAP
$3.19M 0.05%
400,000
– –
DFHTU
106
DELISTED
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
$3.19M 0.05%
+300,000
New +$3.16M
GRTX
107
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.94M 0.04%
325,000
– –
REGN icon
108
Regeneron Pharmaceuticals
REGN
$79.7B
$2.8M 0.04%
5,000
-10,000
-67% -$6.06M
TRIL
109
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.63M 0.02%
114,674
– –
LVGO
110
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$1.49M 0.02%
10,663
-2,957
-22% -$360K
RACE icon
111
Ferrari
RACE
$71.5B
$1.14M 0.02%
6,200
– –
EIGR
112
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.14M 0.02%
4,663
– –
TGTX icon
113
TG Therapeutics
TGTX
$8.12B
$907K 0.01%
33,893
+4,131
+14% +$95.1K
LEGN icon
114
Legend Biotech
LEGN
$3.44B
$772K 0.01%
25,000
– –
CLDX icon
115
Celldex Therapeutics
CLDX
$3.02B
$738K 0.01%
+49,751
New +$583K
SRRA
116
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$711K 0.01%
66,655
– –
AKRO
117
DELISTED
Akero Therapeutics
AKRO
$675K 0.01%
+21,938
New +$767K
CVET
118
DELISTED
Covetrus, Inc. Common Stock
CVET
$636K 0.01%
+26,075
New +$562K
PSNL icon
119
Personalis
PSNL
$1.72B
$591K 0.01%
+27,272
New +$542K
REPL icon
120
Replimune Group
REPL
$1.23B
$443K 0.01%
+19,230
New +$438K
BIO icon
121
Bio-Rad Laboratories Class A
BIO
$10.1B
$252K ﹤0.01%
489
-15,000
-97% -$7.6M
OTLKW
122
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$54K ﹤0.01%
420,875
– –
AGIO icon
123
Agios Pharmaceuticals
AGIO
$1.96B
– –
-900,000
Closed -$48.1M
AKBA icon
124
Akebia Therapeutics
AKBA
$250M
– –
-52,724
Closed -$716K
ALEC icon
125
Alector
ALEC
$228M
– –
-511,731
Closed -$12.5M
2 3 4
5
6

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Perceptive Advisors held 155 positions worth $6.85B, up 11% from $6.17B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perceptive Advisors withdrew a net $555M in Q3 2020, closing 29 positions and reducing 23 holdings. Its most notable exit was Zogenix, Inc., an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Outset Medical worth $142M.

  • Perceptive Advisors's largest Q3 2020 buy was Outset Medical: 189,855 shares worth $142M.
  • Perceptive Advisors added most to Mirati Therapeutics, Inc. Common Stock in Q3 2020, an estimated $90.9M increase.
  • Perceptive Advisors's biggest Q3 2020 reduction was Kodiak Sciences, cutting an estimated $124M.
  • Perceptive Advisors fully exited Zogenix, Inc. in Q3 2020, selling an estimated $133M.
  • Perceptive Advisors's ten largest holdings make up 44% of its $6.85B portfolio in Q3 2020.
  • Perceptive Advisors opened 30 new positions and closed 29 in Q3 2020.
  • Perceptive Advisors's portfolio value rose 11% quarter-over-quarter to $6.85B.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.